Core Viewpoint - Deep Longevity, Inc. plans to expand into the U.S. market in Q1 2026, targeting the rapidly growing health market valued at over $6.8 trillion [1][2]. Group 1: Expansion Plans - Deep Longevity will establish a local sales team in the U.S., with the first two sales personnel joining on January 1, 2026 [2]. - The initial focus of the sales team will be on the Southeastern U.S. states, including Alabama, Arkansas, Florida, Georgia, Kentucky, Louisiana, Mississippi, North Carolina, South Carolina, Tennessee, Virginia, and West Virginia [2]. Group 2: Product Offerings - The company offers clinically validated aging clocks, including BloodAge, MindAge, BiometricAge, EpigeneticAge, and the upcoming FaceAge, which provide multi-dimensional biological age assessments beyond chronological age [1][2]. - Deep Longevity's technology is supported by numerous peer-reviewed papers and patents, integrating blood biomarkers, epigenetics, psychology, and biology to deliver comprehensive biological aging profiles [2]. Group 3: Business Model - Deep Longevity provides vertical software-as-a-service (SaaS) solutions that offer personalized recommendations to improve health and extend healthy lifespan [3].

Deep Longevity, Inc(本公司之一家全资附属公司，Deep Longevity)于本年度上半年在新客户拓展方面持 续取得进展，其中值得注意 的新客户包括中国香港的仁山医疗(https://www.humansahealth.com)及印度 的Holistica World (https://www.holisticaworld.com)。此外，与去年同期相比，本年度上半年客户对Deep Longevity的老化时钟的使用量有所增加，显示了技术的价值，以及长寿及保健作为一种健康趋势日益 受到关注。Deep Longevity旨在与采用B2C模式的长寿应用程式、其他平台、初创企业以及诊断公司建 立新的合作伙伴关系。 Deep Longevity致力于最大的长寿市场美国(美国)推出老化时钟，并委聘一名美国总裁领导该市场的拓 展工作，相信这将推动业务增长。值得注意的是，虽然长寿与保健市场仍处于发展初期，但此项独特的 技术旨在进入这个极为庞大且不断成长的市场，估算该市场于2023年的价值超过6.3万亿美元。 Deep Longevity拥有活跃的渠道，目前正与巴西、德国及东南亚等市场的多间长寿诊所及其他 ...